A new study reveals the majority of nursing homes favor treating patients with atypical antipsychotics.
Using a variety of data sources, including Medicaid and Medicare data, the researchers identified 65,618 patients 65 years or older residing in nursing homes in 45 states.
All had started treatment with an antipsychotic after their admission between 2001 and 2005.
Nearly half of the nursing homes studied (45%) never prescribed a conventional antipsychotic medication.
In fact, 91.2% of patients started treatment with an atypical medication. Of the 8.8% of patients treated with a conventional medication, the most frequently prescribed drugs were haloperidol (86%) and chlorpromazine (8%).
See the complete study at Huybrechts, K.F. et al. (2012). Variation in antipsychotic treatment choice across US nursing homes. Journal of Clinical Psychopharmacology, 32(1), 11-17.